Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 11,097 | 10,818 | 9,856 | 12,598 | 11,038 |
| Cost of Goods | 4,891 | 4,358 | 3,807 | 4,830 | 4,069 |
| Gross Profit | 6,206 | 6,460 | 6,049 | 7,768 | 6,969 |
| Operating Expenses | 14,119 | 12,432 | 11,264 | 10,954 | 10,064 |
| Operating Income | -7,022 | -5,614 | -4,408 | -2,356 | -3,026 |
| Interest Expense | 551 | 450 | 372 | 355 | 393 |
| Other Income | -34 | 755 | -168 | -321 | 199 |
| Pre-tax Income | -7,607 | -5,309 | -4,948 | -3,032 | -3,220 |
| Income Tax | -11 | 4 | -3 | 3 | 41 |
| Net Income Continuous | -7,596 | -5,313 | -4,945 | -3,035 | -3,261 |
| Net Income | $-7,596 | $-5,313 | $-4,945 | $-3,035 | $-3,261 |
| EPS Basic Total Ops | -0.04 | -0.02 | -0.03 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.04 | -0.03 | -0.03 | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.04 | -0.02 | -0.03 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.04 | -0.03 | -0.03 | -0.02 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.03 | -0.03 | -0.02 | -0.02 |
| EBITDA(a) | $-5,829 | $-4,436 | $-3,255 | $-1,209 | $-1,937 |